Thyroid Diseases
Welcome,         Profile    Billing    Logout  
 62 Companies   89 Products   89 Products   76 Mechanisms of Action   2 Trials   652 News 


«12345678910111213...1314»
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial primary completion date:  Vandetanib Risk Minimisation Effectiveness (clinicaltrials.gov) -  Jun 13, 2014   
    P=N/A,  N=12, Completed, 
    Recruiting --> Completed Trial primary completion date: Dec 2014 --> Feb 2014
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Enrollment change:  Vandetanib Risk Minimisation Effectiveness (clinicaltrials.gov) -  Jun 13, 2014   
    P=N/A,  N=12, Completed, 
    Trial primary completion date: Dec 2014 --> Feb 2014 N=20 --> 12
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial completion, Enrollment change, Trial primary completion date:  Vandetanib Risk Minimisation Effectiveness (clinicaltrials.gov) -  Jun 13, 2014   
    P=N/A,  N=12, Completed, 
    N=20 --> 12 Active, not recruiting --> Completed | N=20 --> 12 | Trial primary completion date: Dec 2014 --> Feb 2014
  • ||||||||||  Iclusig (ponatinib) / Takeda
    Enrollment change:  Ponatinib for Advanced Medullary Thyroid Cancer (clinicaltrials.gov) -  Jun 6, 2014   
    P2,  N=31, Recruiting, 
    Active, not recruiting --> Completed | N=20 --> 12 | Trial primary completion date: Dec 2014 --> Feb 2014 N=48 --> 31
  • ||||||||||  Enrollment closed:  Iodine Supplementation in Obesity (clinicaltrials.gov) -  Jun 1, 2014   
    P=N/A,  N=162, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Enrollment open:  The Diagnostic Value of Shear Wave Elastography (clinicaltrials.gov) -  May 28, 2014   
    P=N/A,  N=400, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date, Metastases:  Study of External Beam Radiotherapy to Thyroid Carcinoma (clinicaltrials.gov) -  May 25, 2014   
    P2,  N=50, Recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Nov 2012 --> Dec 2015
  • ||||||||||  Trial completion date, Metastases:  Study of External Beam Radiotherapy to Thyroid Carcinoma (clinicaltrials.gov) -  May 25, 2014   
    P2,  N=50, Recruiting, 
    Trial primary completion date: Nov 2012 --> Dec 2015 Trial completion date: Nov 2012 --> Dec 2015
  • ||||||||||  buparlisib (AN2025) / Novartis, Adlai Nortye
    Trial primary completion date, Metastases:  A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies (clinicaltrials.gov) -  May 18, 2014   
    P1,  N=53, Recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Jan 2014 --> Jan 2015
  • ||||||||||  buparlisib (AN2025) / Novartis, Adlai Nortye
    Trial completion date, Metastases:  A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies (clinicaltrials.gov) -  May 18, 2014   
    P1,  N=53, Recruiting, 
    Trial primary completion date: Apr 2014 --> Apr 2018 Trial completion date: Feb 2015 --> Feb 2016
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Enrollment open:  CaprelsaReg: CAPRELSA (clinicaltrials.gov) -  May 18, 2014   
    P=N/A,  N=15, Recruiting, 
    Trial completion date: Feb 2015 --> Feb 2016 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date:  Differential Diagnosis of STA-PSV in Thyrotoxicosis (clinicaltrials.gov) -  May 1, 2014   
    P=N/A,  N=169, Completed, 
    Trial primary completion date: Jul 2013 --> May 2015 Trial primary completion date: Apr 2014 --> Nov 2011
  • ||||||||||  Trial completion date:  Differential Diagnosis of STA-PSV in Thyrotoxicosis (clinicaltrials.gov) -  May 1, 2014   
    P=N/A,  N=169, Completed, 
    Trial primary completion date: Apr 2014 --> Nov 2011 Trial completion date: Apr 2014 --> Nov 2011
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial completion date, Monotherapy, Metastases:  A Study To Assess ZD6474 (ZACTIMA (clinicaltrials.gov) -  Apr 16, 2014   
    P2,  N=22, Active, not recruiting, 
    Active, not recruiting --> Completed Trial completion date: Mar 2014 --> Mar 2015
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial completion date, Metastases:  Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer (clinicaltrials.gov) -  Apr 16, 2014   
    P2,  N=40, Active, not recruiting, 
    Trial completion date: Mar 2014 --> Mar 2015 Trial completion date: Mar 2014 --> Mar 2015